Optas LLC’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Sell |
14,977
-597
| -4% | -$41.7K | 0.2% | 63 |
|
|
2025
Q1 | $1.14M | Buy |
15,574
+229
| +1% | +$16.8K | 0.2% | 55 |
|
|
2024
Q4 | $1.01M | Sell |
15,345
-225
| -1% | -$14.7K | 0.22% | 60 |
|
|
2024
Q3 | $1.21M | Buy |
15,570
+9,877
| +173% | +$770K | 0.28% | 52 |
|
|
2024
Q2 | $444K | Buy |
5,693
+1,345
| +31% | +$105K | 0.11% | 102 |
|
|
2024
Q1 | $295K | Sell |
4,348
-738
| -15% | -$50K | 0.08% | 142 |
|
|
2023
Q4 | $343K | Buy |
5,086
+418
| +9% | +$28.2K | 0.1% | 118 |
|
|
2023
Q3 | $316K | Buy |
4,668
+526
| +13% | +$35.6K | 0.11% | 112 |
|
|
2023
Q2 | $296K | Buy |
4,142
+317
| +8% | +$22.7K | 0.1% | 121 |
|
|
2023
Q1 | $265K | Sell |
3,825
-220
| -5% | -$15.3K | 0.09% | 131 |
|
|
2022
Q4 | $274K | Sell |
4,045
-395
| -9% | -$26.8K | 0.11% | 117 |
|
|
2022
Q3 | $242K | Buy |
4,440
+872
| +24% | +$47.5K | 0.11% | 115 |
|
|
2022
Q2 | $236K | Buy |
3,568
+476
| +15% | +$31.5K | 0.1% | 121 |
|
|
2022
Q1 | $205K | Sell |
3,092
-331
| -10% | -$21.9K | 0.07% | 141 |
|
|
2021
Q4 | $200K | Buy |
+3,423
| New | +$200K | 0.06% | 142 |
|
|
2020
Q4 | – | Sell |
-5,007
| Closed | -$275K | – | 143 |
|
|
2020
Q3 | $275K | Buy |
+5,007
| New | +$275K | 0.08% | 133 |
|